Anil Abraham Joy BSc, MD, FRCPC

Dr. Anil Abraham Joy is a Professor in the Department of Oncology, Division of Medical Oncology in the Faculty of Medicine and Dentistry at the University of Alberta and a staff medical oncologist at the Cross Cancer Institute in Edmonton, Alberta. In addition to his other appointments, he has previously served as Chair for the Northern Alberta Breast Cancer Program and the Provincial Chair for the Alberta Breast Cancer Program. He currently serves as a member of the pan-Canadian Oncology Drug Review (pCODR) Expert Review Committee (pERC) where they assess the clinical evidence and cost-effectiveness of cancer drugs in order to make recommendations to the provinces and territories to help guide their drug funding decisions. His primary oncologic clinical and research areas of interest include breast and thoracic malignancies. He has an interest in medical education, Phase II/III clinical and translational research in breast and thoracic malignancies, cardio-oncology-exercise research, clinical guideline development, and global oncology/regional disparity issues.